SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BELLINI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.349
AS - Asia 8.746
EU - Europa 5.143
SA - Sud America 1.310
AF - Africa 216
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
Totale 29.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.058
SG - Singapore 3.255
CN - Cina 2.260
IT - Italia 1.085
BR - Brasile 1.018
VN - Vietnam 945
UA - Ucraina 804
DE - Germania 784
HK - Hong Kong 726
TR - Turchia 557
GB - Regno Unito 481
PL - Polonia 407
FI - Finlandia 369
FR - Francia 291
JP - Giappone 255
RU - Federazione Russa 238
SE - Svezia 227
IN - India 168
CA - Canada 134
MX - Messico 123
ID - Indonesia 110
AR - Argentina 105
BD - Bangladesh 93
NL - Olanda 85
ZA - Sudafrica 79
IQ - Iraq 60
BE - Belgio 53
ES - Italia 49
CO - Colombia 46
AT - Austria 43
CZ - Repubblica Ceca 41
EC - Ecuador 40
EE - Estonia 37
PK - Pakistan 34
VE - Venezuela 33
PH - Filippine 30
SA - Arabia Saudita 28
MY - Malesia 27
MA - Marocco 26
UZ - Uzbekistan 26
LT - Lituania 24
IR - Iran 22
CL - Cile 21
KR - Corea 20
AE - Emirati Arabi Uniti 18
PY - Paraguay 18
TN - Tunisia 18
ET - Etiopia 17
KE - Kenya 16
NP - Nepal 16
AU - Australia 15
EG - Egitto 15
BG - Bulgaria 14
DZ - Algeria 14
IE - Irlanda 14
AZ - Azerbaigian 12
RO - Romania 12
UY - Uruguay 12
PE - Perù 11
JO - Giordania 10
AL - Albania 9
EU - Europa 9
IL - Israele 9
JM - Giamaica 9
PT - Portogallo 9
SD - Sudan 9
KZ - Kazakistan 8
AO - Angola 7
BY - Bielorussia 7
CH - Svizzera 7
LB - Libano 7
OM - Oman 7
RS - Serbia 7
BO - Bolivia 6
DK - Danimarca 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
GE - Georgia 5
GR - Grecia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
KW - Kuwait 4
MD - Moldavia 4
NI - Nicaragua 4
PA - Panama 4
DJ - Gibuti 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
QA - Qatar 3
TH - Thailandia 3
ZW - Zimbabwe 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
Totale 29.764
Salva come PNG Salva come JPEG
Città #
Singapore 2.100
Ashburn 1.484
Woodbridge 1.185
Fairfield 986
Chandler 927
San Jose 888
Jacksonville 884
Beijing 712
Houston 709
Hong Kong 708
Ann Arbor 684
Santa Clara 678
Wilmington 409
Warsaw 391
Seattle 361
Dallas 316
Izmir 312
Cambridge 299
Ho Chi Minh City 290
Nanjing 255
Tokyo 246
Ferrara 241
Los Angeles 224
Hanoi 217
Princeton 207
Munich 185
Lauterbourg 170
Boardman 168
Helsinki 127
New York 127
Dearborn 123
Milan 122
Council Bluffs 104
Nanchang 95
São Paulo 90
Shanghai 88
Shenyang 87
Mexico City 77
San Diego 77
Addison 74
Tianjin 67
London 66
Turku 66
Changsha 65
Jakarta 65
Orem 59
Bologna 58
Chennai 54
Buffalo 52
Hebei 52
Bremen 50
Da Nang 50
Brussels 47
Hefei 46
Jiaxing 46
Montreal 45
Brooklyn 44
Chicago 43
Rome 43
Frankfurt am Main 42
Toronto 42
Moscow 41
Haiphong 38
Johannesburg 37
Jinan 36
Phoenix 34
Brno 33
Norwalk 33
Stockholm 33
Denver 32
Orange 32
Poplar 32
Ningbo 31
The Dalles 31
Vienna 31
Boston 30
San Francisco 30
Manchester 29
Guangzhou 28
Rio de Janeiro 28
Curitiba 27
Atlanta 25
Redwood City 25
Hải Dương 23
Kunming 22
Amsterdam 21
Ankara 21
Baghdad 21
Mountain View 21
Tashkent 21
Auburn Hills 20
Belo Horizonte 20
Leawood 20
Augusta 19
Brasília 19
Zhengzhou 19
Düsseldorf 18
San Mateo 18
Dong Ket 17
Charlotte 16
Totale 19.561
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 412
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 293
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 279
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 271
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 246
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 245
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 245
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 239
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 238
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 235
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 224
Chimica Medica e propedeutica Biochimica 222
Evaluation of a possible role of oxidative stress in climacteric symptoms. 221
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 221
A rapid method for purification of myelin basic protein 220
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 215
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 213
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 213
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 205
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 203
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 203
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 203
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 201
Activation of the sendai virus fusion protein by receptor binding 200
Activation of the Sendai virus fusion protein by receptor binding 198
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 198
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 197
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 196
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 193
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 190
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 188
Mutual communication of envelope glycoproteins of paramixoviruses 188
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 186
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 186
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 186
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 185
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 185
Analisi della proteina basica della mielina nel liquor 183
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 183
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 182
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 182
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 181
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 181
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 180
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 178
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 177
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 177
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 177
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 175
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 175
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 174
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 174
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 171
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 171
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 168
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 168
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 167
Biochemical study in adult population with stroke in Ferrara, Fabry disease 166
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 164
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 164
null 163
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 162
A catalytic tyrosine at the active site of sendai virus neuraminidase 161
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 161
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 160
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 160
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 157
Anomeric specificity of the neuraminidase from sendai virus 157
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 155
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 155
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 153
Evidence for multiple pairs of vicinal thiols in some proteins 153
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 152
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 151
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 150
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 148
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 147
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 147
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 146
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 146
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 146
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 144
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 144
Gender differences in audio-vestibular disorders 143
The effect of inorganic phosphate on the stability of some enzymes 142
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 142
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 141
Pain in head and neck cancer patients: The role of gender 141
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 141
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 140
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 140
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 140
Domain structure of the hemagglutinin-neuraminidase from sendai virus 140
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 138
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 138
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 137
Purification of transglutaminase enzyme from L. infantum promastigotes 137
Totale 18.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 678
Totale 132.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021777 0 0 0 0 0 0 0 0 0 328 332 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/202611.184 1.119 552 1.168 1.547 1.634 781 1.458 660 1.147 1.118 0 0
Totale 30.133